EL
ANVS icon

Essex LLC’s Annovis Bio ANVS Stock Holding History

Essex LLC’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,408
Closed -$118K – 147
2022
Q2 		$118K Sell
10,408
-1,185
-10% -$13K 0.04% 152
2022
Q1 		$155K Buy
11,593
+1,000
+9% +$14.4K 0.04% 163
2021
Q4 		$186K Sell
10,593
-1,369
-11% -$35.3K 0.05% 170
2021
Q3 		$380K Buy
+11,962
New +$688K 0.11% 134

Other funds holding ANVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Essex LLC's ANVS Position: Q3 2022 in Review

Essex LLC sold out of Annovis Bio (ANVS) in Q3 2022, closing a stake of 10,408 shares — an estimated $118K sold.

Essex LLC first reported a position in ANVS in Q3 2021 and held it in 4 quarters. The position peaked at $380K in Q3 2021. 25 funds tracked by Wall St. Rank hold ANVS as of Q3 2022.

  • Essex LLC reported no remaining Annovis Bio position as of Q3 2022 after selling out during the quarter.
  • Essex LLC sold 10,408 Annovis Bio shares in Q3 2022, an estimated $118K.
  • Essex LLC first reported a position in Annovis Bio in Q3 2021 and held it in 4 quarters.
  • Essex LLC's Annovis Bio position peaked at $380K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2022.

Based on Essex LLC's 13F filing for Q3 2022, filed 7 Nov 2022.